SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CUBIST PHARMACEUTICALS (CBST)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
252 31 0 CBST
Emcee:  Weekapaug Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
127Anybody listen to the CC? Analysts were expecting revenues of $26 million, so $tuck-4/20/2005
126I am just exhausted holding this dang thing. Someone please put cbst out of my mkeokalani'nui-3/22/2005
125[Cubist buys a 2% royalty reduction for ~1.9M shares] >>LEXINGTON, Mass.-tuck-3/3/2005
124Wife, Relative of Cubist Ex-CEO Are Accused of Insider Trading By SIOBHAN HUGHEDoc Bones-1/14/2005
123Short interest position is the highest it's been all year.richardred-12/26/2003
122Avantis-Waiting on Ketek approval infectioncontroltoday.comrichardred-12/18/2003
121Pfizer now merged with Pharmacia-Zyvox Zithromax sales -355 million through the richardred-12/18/2003
120Antibacterials - Death of the Blockbuster? the-infoshop.comrichardred-12/17/2003
119Gene Transfer Leads To Antibiotic Resistance In Staph Strain tigr.org MRSA-superichardred-12/17/2003
118Pfizer's-Zithromax- cincinnati.bizjournals.comrichardred-12/17/2003
117Glaxosmithkline's -Augmentin pubs.acs.org Total groups sales of all Anti-barichardred-12/17/2003
116IMO-This company look shaky-no FDA approval-scamish. s-ilversource.com amsilverrichardred-12/17/2003
115Bayer-Cipro theunadvertisedbrand.comrichardred-12/17/2003
114Sorry-No- I put it there for my reference. I'm trying to guess the Market porichardred-12/17/2003
113I'm sorry, is there nexus between your remarks and link?keokalani'nui-12/17/2003
112Abbott's Biaxin- parpharm.comrichardred-12/17/2003
111The down fall- The cost of using daptomycin is likely higher than comparative drrichardred-12/17/2003
110wide trading range intraday with support on breaks below 12.richardred-12/11/2003
109from Ron Garren: At 9.45 AM PST bought 4000 shares of Cubist (CBST) at $10.92/stom pope-10/17/2003
108Secondary out the door. Details? quote.bloomberg.com Cubist Pharmaceuticals RaJoe Wesley-10/15/2003
107Biotech Vs. Bacteria A Better Antibiotic? Matthew Herper [Forbes], 07.09.03, 7:0sim1-7/9/2003
106Guess nothing is a slam dunk. biz.yahoo.comJoe Wesley-6/19/2003
105Cubist Pharmaceuticals Presents First Human Data on Investigational Antibiotic Cnigel bates-5/13/2003
104FDA Accepts CIDECIN NDA and Grants Priority Review Status LEXINGTON, Mass.--(BUnigel bates-2/20/2003
103LEXINGTON, Mass.--(BUSINESS WIRE)--Dec. 20, 2002--Cubist Pharmaceuticals, Inc. (nigel bates-12/20/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News